Modified Directly Observed Therapy for Antiretroviral Therapy: A Primer from the Field
- 1 July 2007
- journal article
- research article
- Published by SAGE Publications in Public Health Reports®
- Vol. 122 (4) , 472-481
- https://doi.org/10.1177/003335490712200408
Abstract
Modified directly observed therapy (mDOT), in which a portion of total doses of a medication regime is ingested under supervision, has demonstrated efficacy as an intervention to assist patients in maintaining adherence to complicated antiretroviral therapy (ART). Although findings are favorable, existing efficacy studies fail to provide sufficient detail to guide others who wish to implement mDOT interventions. The aim of this article is to provide a primer for practitioners and researchers who wish to implement mDOT interventions. Drawing on the experience of 10 federally funded research projects, we provide guidance on critical questions for program implementation, including: who should be targeted, length/duration/content/location/tapering of sessions, staffing, incentives, and approaches to data collection. In addition, guidance on staff training and minimum requirements for mDOT interventions is offered along with real-world examples of mDOT interventions. mDOT is feasible and easily adapted to many settings and target populations. Interventions should match the specific needs of the target population and setting and be flexible in terms of design and delivery. mDOT should be considered among the spectrum of adherence interventions.Keywords
This publication has 27 references indexed in Scilit:
- Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counselingAIDS Care, 2007
- Case Management Is Associated with Improved Antiretroviral Adherence and CD4+Cell Counts in Homeless and Marginally Housed Individuals with HIV InfectionClinical Infectious Diseases, 2006
- A Randomized Trial of Directly Administered Antiretroviral Therapy and Adherence Case Management InterventionClinical Infectious Diseases, 2006
- Modeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and DeathClinical Infectious Diseases, 2004
- Developing a Directly Administered Antiretroviral Therapy Intervention for HIV-Infected Drug Users: Implications for Program ReplicationClinical Infectious Diseases, 2004
- Improving on successAIDS, 2004
- Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)AIDS, 2001
- Directly Observed Therapy in HIV Therapy: A Realistic Perspective?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998